FWM
IRD

Frontier Wealth Management’s Opus Genetics IRD Stock Holding History

Frontier Wealth Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$35K Sell
18,000
-3,000
-14% -$6.82K ﹤0.01% 385
2022
Q1 		$59K Buy
21,000
+3,000
+17% +$10.3K ﹤0.01% 394
2021
Q4 		$67K Sell
18,000
-7,000
-28% -$28.1K ﹤0.01% 417
2021
Q3 		$129K Buy
+25,000
New +$115K 0.01% 404

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Frontier Wealth Management's IRD Position: Q2 2022 in Review

Frontier Wealth Management reduced its Opus Genetics (IRD) stake by 14% in Q2 2022, selling an estimated $6.82K and leaving 18,000 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #385.

Frontier Wealth Management first reported a position in IRD in Q3 2021 and has held it in 4 quarters since. The position peaked at $129K in Q3 2021. 38 funds tracked by Wall St. Rank hold IRD as of Q2 2022.

  • Frontier Wealth Management held 18,000 shares of Opus Genetics worth $35K as of Q2 2022.
  • Frontier Wealth Management sold 3,000 Opus Genetics shares in Q2 2022, an estimated $6.82K.
  • Opus Genetics made up ﹤0.01% of Frontier Wealth Management's portfolio in Q2 2022, its #385 holding.
  • Frontier Wealth Management first reported a position in Opus Genetics in Q3 2021 and has held it in 4 quarters since.
  • Frontier Wealth Management's Opus Genetics position peaked at $129K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.